ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO549

Resveratrol Ameliorates High-Phosphate-Induced VOT and AMC in CKD Through Regulating Wnt/β-Catenin Signaling

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic


  • Huang, Xiaowen, Nanjing Medical University, Nanjing, China
  • He, Weichun, Nanjing Medical University, 2nd Affiliated Hospital, Nanjing, JIANGSU , China

Vascular smooth muscle cells (VSMCs) to osteoblast-like cells transdifferentiation (VOT) induced by high-phosphate is a crucial step in the development of arterial medial calcification (AMC) in patients with chronic kidney disease (CKD). Our previous study demonstrated that Wnt/β-catenin signaling played an important role in promoting VOT and calcification in VSMCs induced by high-phosphate. Studies in cancer field have confirmed that resveratrol, a natural polyphenol, could regulate Wnt/β-catenin signaling. However, the potential effect of resveratrol on VOT and AMC through Wnt/β-catenin signaling remains to be elucidated.


An animal model of chronic renal failure with AMC was established by feeding rats a diet containing 0.75% adenine and 0.9% phosphorus. VOT and AMC in arterial ring was induced by placing isolated thoracic aortic rings from mice in culture medium containing 10 mM β-glycerophosphoric acid (β-GP). VOT and calcification of cultured VSMCs was also induced by 10 mM β-GP. The effect of resveratrol on VOT and/or calcification was observed in the in vivo, ex vivo and in vitro models mentioned above. The regulation of resveratrol on Wnt/β-catenin signaling in VSMCs was also examined.


Resveratrol ameliorated AMC in chronic renal failure rats fed with high-phosphate diet and calcium deposition in arterial rings and VSMCs cultured in a high-phosphate environment. Resveratrol suppressed the induction of Runx2, osteocalcin and osteopontin and restored the expression of SM22α in arterial rings and VSMCs treated with high-phosphate. In vitro, resveratrol inhibited the upregulation of two forms of active β-catenin, dephosphorylated on Ser37/Thr41 and phosphorylated on Ser675 sites, and β-catenin nuclear translocation, stimulated by high-phosphate. Furthermore, porcupine and wntless was induced in VSMCs treated with high-phosphate in a time-dependent manner, which could be inhibited by resveratrol. Resveratrol also inhibited the phosphorylation of LRP6 induced by high-phosphate. However, it seemed that resveratrol couldn't inhibit the expression of Runx2 induced by Wnt3a.


The results presented in our study suggest that through targeting Wnt/β-catenin signaling, which in turn impeding VOT induced by high-phosphate, resveratrol possesses an effect on retarding AMC in CKD.


  • Government Support - Non-U.S.